Method and system for determining drug delivery amount in clinical trials
By dynamically adjusting the dose of the subjects, and according to the dynamic dose conditions and drug delivery rules, the problems of drug waste and calculation errors in clinical trials were solved, achieving the accuracy and cost savings of drug use.
Patent Information
- Application Number
- CN202111188728.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-12
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-10-12
AI Technical Summary
In clinical trials, traditional drug distribution methods lead to drug waste and calculation errors, especially when subjects exit midway or change in weight, the remaining drugs cannot be reused, increasing the cost of the trial.
By obtaining the subject's dynamic dosage conditions and drug delivery rules, dynamically adjust the subject's drug delivery dosage, avoid calculating and preparing too many drugs in advance, and use calculation rules and adjustment rules to determine the drug delivery dosage of the current visit. Change or maintain the dose of the drug sent in the last visit, and adjust it according to the preset conditions.
It reduces drug waste and artificial calculation errors, improves the accuracy of drug delivery, saves trial costs, and is suitable for different clinical projects.
Smart Images

Figure CN113971997B_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of clinical trials, and in particular to a method and system for determining the amount of drugs to be dispensed in clinical trials. Background Art
[0002] In clinical trials, the traditional method of distributing trial drugs is usually to prepare all the drugs for each subject for each visit during the entire medical clinical trial before the trial, and then distribute the prepared drugs during the clinical trial.
[0003] A visit refers to a specific process in medical clinical trials for researchers to obtain information from subjects. During each visit, researchers will distribute the prepared drugs to subjects. Since the test drugs for the entire clinical trial period are prepared in advance for the subjects, in this case, if one or some subjects withdraw from the trial for some reason, such as a subject withdrawing from the trial, terminating the trial, or experiencing other situations such as weight changes, the remaining drugs can no longer be used. Since the test drugs for the subject have been provided to the research center, other research centers cannot use them, resulting in a large amount of drug waste and increased trial costs.
[0004] Therefore, there is an urgent need to provide a new solution to solve the problem of drug waste when dispensing drugs to clinical trial subjects. Summary of the invention
[0005] In view of this, the embodiments of the present application provide a method and system for determining the amount of medicine to be dispensed in clinical trials, which can reduce human calculation errors in the process of drug distribution in clinical trials, save the amount of medicine to be dispensed, and avoid unnecessary waste of medicines.
[0006] In a first aspect, the present application provides a method for determining the amount of drug to be dispensed in a clinical trial, comprising:
[0007] Obtaining the dynamic dosage conditions of the subject, which include the dynamic dosage conditions of the subject at the current visit and the dynamic dosage conditions of the subject at the previous visit;
[0008] Based on dynamic dosage conditions, the amount of medication dispensed to the subject during the current visit is determined according to the medication dispensing rules.
[0009] In one embodiment, the medication dispensing rules include: calculation rules and adjustment rules, wherein:
[0010] The calculation rule includes dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels;
[0011] The adjustment rule includes that as the dynamic dosage conditions of the subject at the current visit change relative to the dynamic dosage conditions of the subject at the previous visit, the drug dosage level of the subject's medication dispensed at the current visit will change or remain unchanged based on the drug dosage level of the subject's medication dispensed at the previous visit.
[0012] In one embodiment, based on the dynamic dosage condition, determining the final medication amount to be dispensed to the subject in the current visit according to the medication dispensing rules includes:
[0013] Obtain the dynamic dosage conditions of the subject's last visit and the amount of medication dispensed at the subject's last visit;
[0014] Analyze dynamic dosage conditions and determine the medication dosage for the subject during the current visit based on the medication dosage at the subject's previous visit according to medication dispensing rules.
[0015] In one embodiment, the dynamic dosage condition is analyzed, and according to the medication dispensing rules, the medication dispensing amount for the subject in the current visit is determined based on the medication dispensing amount for the subject in the previous visit, including:
[0016] Determine whether the dynamic dosage conditions of the subject at the current visit have changed relative to the dynamic dosage conditions of the subject at the previous visit;
[0017] If not, the medication amount of the subject at the last visit is output as the medication amount of the subject at the current visit;
[0018] If so, it is necessary to further determine whether the change meets the preset conditions;
[0019] If the preset conditions are not met, the amount of medicine dispensed at the subject's last visit will be output as the amount of medicine dispensed at the subject's current visit;
[0020] If the preset conditions are met, the medication amount of the subject at the previous visit is adjusted to determine a new medication dosage level, and the new medication dosage level is output as the medication amount of the subject at the current visit.
[0021] In one embodiment, the preset condition includes: a first preset condition and a second preset condition, wherein:
[0022] The first preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's previous visit is greater than or equal to the first preset threshold value A1 and less than or equal to the second preset threshold value A2, that is, A1≤|Q2-Q1|≤A2;
[0023] The second preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's previous visit is greater than a second preset threshold, |Q2-Q1|>A2.
[0024] In one embodiment, adjusting the medication dose dispensed by the subject at the last visit to determine a new medication dosage level comprises:
[0025] When the change satisfies the first preset condition, the new drug dosage level is determined by increasing or decreasing the drug dosage level of the drug dispensing amount of the subject at the last visit within the dosage condition interval to which the dynamic dosage condition of the subject at the last visit belongs;
[0026] When the change meets the second preset condition, a new dosage condition interval is adjusted and determined based on the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and the drug dosage level is determined within the new dosage condition interval as the new drug dosage level according to the dynamic dosage condition of the subject's current visit.
[0027] In one embodiment, the method further comprises:
[0028] Determine whether the subject's current visit is the subject's first visit;
[0029] If yes, record the dynamic dosage conditions of the subject's first visit, and determine and record the amount of medication dispensed for the subject's first visit according to the medication dispensing rules;
[0030] If not, record the dynamic dosage conditions of the subject's current visit, obtain the dynamic dosage conditions of the subject's previous visit and the amount of medicine dispensed during the subject's previous visit, and determine and record the amount of medicine dispensed during the subject's current visit according to the medicine dispensing rules. In one embodiment, determining the amount of medicine dispensed during the subject's first visit according to the medicine dispensing rules includes:
[0031] According to the calculation rules, after confirming the dose condition interval corresponding to the dynamic dose condition of the subject's first visit, the drug dose level corresponding to the dose condition interval is obtained and defined as the first dose level, and the first dose level is used as the drug dispensing amount for the subject's first visit; wherein,
[0032] The calculation rule includes dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels.
[0033] In one embodiment, the method further comprises:
[0034] After determining the amount of medication dispensed by the subject at the current visit, further determine whether the current visit of the subject is the subject's last visit;
[0035] If no, proceed to obtain dynamic dosing conditions for the subject;
[0036] If yes, end the medication dispensing process for the subject.
[0037] In a second aspect, the present application also provides a system for clinical trials, the system comprising:
[0038] An acquisition module, used to obtain the dynamic dosage conditions of the subjects and the drug dispensing rules of the clinical trial;
[0039] The determination module is used to determine the amount of medicine to be dispensed to the subject in the current visit based on dynamic dosage conditions and according to the medication dispensing rules.
[0040] In a third aspect, the present application also provides a computer-readable storage medium, the storage medium storing a computer program, and the computer program is used to execute any of the above methods for determining the amount of medicine to be dispensed in a clinical trial.
[0041] In a fourth aspect, the present application further provides an electronic device, the electronic device comprising:
[0042] processor;
[0043] a memory for storing processor-executable instructions;
[0044] The processor is used to execute any of the above methods for determining the amount of medicine to be dispensed in clinical trials.
[0045] The present application provides a method for determining the amount of medicine to be dispensed in a clinical trial, and achieves the following technical effects by designing the logic between the medicine dispensing rules and the dynamic dosage conditions: the method determines the amount of medicine required for the subject during the current visit through the subject's dynamic dosage conditions and the medicine dispensing rules, and does not require the subject's medicine dispensing amount to be calculated and prepared in advance at the beginning of the clinical trial, thereby saving the amount of medicine to be dispensed. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] Figure 1 This is a flowchart of an exemplary method for determining the amount of medication to be dispensed in a clinical trial of the present application.
[0047] Figure 2 The present invention is a flowchart of an exemplary method for determining the amount of medication to be dispensed in a clinical trial.
[0048] Figure 3 It is a block diagram of a system for clinical trials provided by an exemplary embodiment of the present application.
[0049] Figure 4 It is a block diagram of an electronic device for a method of determining a drug dosage in a clinical trial provided by an exemplary embodiment of the present application. DETAILED DESCRIPTION
[0050] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0051] Background
[0052] In clinical trial research, the Interactive Web Response System (IWRS) is mainly used for subject randomization, drug management, emergency unblinding, etc.
[0053] Subject randomization means that all subjects participating in the clinical trial are randomly assigned to a treatment factor group, that is, each subject has an equal chance to enter the same treatment factor group, regardless of the subjective will of the researcher or the subject. The purpose of subject randomization is to ensure that other non-treatment factors that may have confounding effects other than the research factors are evenly distributed between groups, so that the baselines between groups are comparable, and at the same time do not affect the efficacy and safety evaluation of the clinical trial.
[0054] In the process of clinical trials, after completing the registration of subjects, screening and randomization of subjects, and visiting subjects, the preparation for drug dosage calculation and distribution will begin. The dosage used by the subjects depends on multiple factors, including the age and gender of the subjects, the exact disease to be treated and its severity, etc. It can be seen that the dosage conditions of the subjects and the rules for dispensing drugs are designed differently according to the different research purposes of different clinical trials. For example, the number of subjects in pharmacokinetic trials is generally around 50, and they are generally divided into 4-5 groups (including single and multiple medications). From the perspective of pharmacokinetic research, it should be required to minimize the differences between groups under the premise of minimizing individual differences (strict inclusion criteria), so as to facilitate the comparison of pharmacokinetic parameters. From a statistical point of view, age, weight, weight coefficient, etc. should maintain a normal distribution. Generally, children's medication is administered by weight and stratified and grouped by weight coefficient. Generally, healthy adult volunteers are selected for adult medication, and medication is not administered by weight. However, when observing pharmacokinetic parameters, the influence of factors such as weight, weight coefficient, and age cannot be ignored, and the interference caused by these factors should be minimized between different groups.
[0055] The existing technology only determines the drug delivery amount based on the dynamic dosage conditions of the subject's current visit, which cannot avoid the problem of incorrect drug delivery. For example, if there is a problem in the dynamic dosage condition acquisition process, the dynamic dosage condition will be incorrect. This error is often not discovered by researchers in time, resulting in incorrect calculation of the drug delivery amount, which not only wastes drugs but also may affect the progress of clinical trials. At the same time, the relationship between dynamic dosage conditions and drug delivery is different in different projects, and the existing technology method cannot be applied to all clinical projects.
[0056] In addition, in previous clinical trials, researchers often calculated the amount of medicine to be given to subjects based on the subjects' dosage information, which could lead to deviations in the amount of medicine given to subjects. Therefore, in order to ensure that subjects have enough medicine to use, researchers usually give more medicine, which results in a waste of medicine. At the same time, in the actual process of dispensing medicine, there is a certain risk of calculation errors due to manual calculation of the amount of medicine to be given.
[0057] In response to the above problems, this application proposes the following technical solutions.
[0058] Example 1
[0059] Figure 1 It is a flowchart of a method for determining the amount of medication to be dispensed in a clinical trial provided by an exemplary embodiment of the present application. Figure 1 The method is performed by a computing device, such as a server. Figure 1 As shown, the method for automatically adjusting the amount of medicine dispensed includes the following contents.
[0060] 110. Obtain the dynamic dosage conditions of the subject, which include the dynamic dosage conditions of the subject at the current visit and the dynamic dosage conditions of the subject at the last visit.
[0061] 120. Based on dynamic dosage conditions, the medication dispensing rules are used to determine the medication dispensing amount for the subject during the current visit.
[0062] Specifically, dosage conditions refer to the conditions of the subjects that affect the dosage of the subjects in clinical trials, such as the height, weight, age, body surface area and other parameter conditions of the subjects. Dynamic dosage conditions refer to dosage conditions that are a variable value, not a constant. For example, the weight in the above dosage conditions is a dynamic dosage condition. Drug dispensing rules refer to the drug administration rules during the clinical trial, which are affected by the dynamic dosage conditions of the subjects. It should be understood that dosage conditions can refer to a combination of multiple parameters, for example, a combination of height and weight, or a combination of age and body surface area, or a combination of more parameters. It should also be understood that dosage conditions can also be obtained by first quantifying these parameters and then performing weighted operations on the quantified parameters.
[0063] According to an embodiment of the present invention, by determining the amount of medicine to be dispensed for a subject during a current visit according to medicine dispensing rules based on the dynamic dosage conditions of the subject during the current visit and the dynamic dosage conditions of the subject during the last visit, it is possible to reduce human calculation errors in the process of drug distribution in clinical trials, and there is no need to calculate the amount of medicine to be dispensed for the subject in advance at the beginning of the clinical trial and prepare it in advance, thereby saving the amount of medicine dispensed and avoiding unnecessary waste of medicine.
[0064] In one embodiment, the medication dispensing rules include: calculation rules and adjustment rules, wherein the calculation rules include dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels; the adjustment rules include that as the dynamic dosage conditions of the subject's current visit change relative to the dynamic dosage conditions of the subject's last visit, the medication dispensing amount of the subject's current visit will change or remain unchanged based on the medication dosage level of the subject's last visit.
[0065] Specifically, through the coordination between the calculation rules and the adjustment rules in the medication dispensing rules, after calculating and obtaining the medication dispensing amount for the first visit, different preset conditions can be set according to the adjustment rules to constrain the medication dispensing amount for subsequent visits, and the medication dispensing amount for the current visit can be automatically adjusted based on the medication dispensing amount for the previous visit, so as to achieve the effect of satisfying the medication needs of the subjects and minimizing the medication dispensing amount, thereby reducing the waste of drugs. In the medication dispensing rules in this embodiment, the medication dosage level required for the current visit is calculated based on the changes in the dynamic dosage conditions of the current visit and the previous visit, and the medication dosage level for the current visit is adjusted (may change or not change) based on the medication dosage level of the previous visit to determine the medication dosage level for the current visit.
[0066] In another embodiment, the medication dispensing rules are not limited to the above-mentioned calculation rules and adjustment rules, and may only include adjustment rules. Specifically, the medication dispensing amount for the first visit of the subject may be determined based on the dynamic dosage conditions, based on historical precipitation data or an optimization model, or may be an initial value set by the researcher based on experience. In this embodiment, based on the dynamic dosage conditions of the subject's first visit and the medication dispensing amount, the medication dispensing amount for the current visit is determined by the adjustment rules.
[0067] In one embodiment, based on dynamic dosage conditions, the amount of medicine dispensed for the subject during the current visit is determined according to the medicine dispensing rules, including: obtaining the dynamic dosage conditions of the subject's last visit and the amount of medicine dispensed for the subject during the last visit; analyzing the dynamic dosage conditions, and according to the medicine dispensing rules, determining the amount of medicine dispensed for the subject during the current visit based on the amount of medicine dispensed for the subject during the last visit.
[0068] According to the embodiments of the present invention, it is not necessary to complete the preparation of all the drugs required by the subjects before the clinical trial, which avoids drug waste. At the same time, the amount of medicine dispensed in the present application is calculated based on the historical data of the drug dispensed in the last visit and the dynamic dosage conditions of the current visit, which can avoid the problem of incorrect drug dispensing due to the possible instability of the data this time. Taking the subject's weight as a dynamic dosage condition as an example, in the clinical trial of non-weight loss products, by observing whether the change between the subject's weight parameters in the last visit and the current visit is abnormal, it can be avoided that the input error or the weighing device error, or even the subject's inconsistency before and after, may be considered. For example, the weight of the first visit is 45kg, and the weight of the second visit is 60kg. Such data with a large difference between the before and after comparison will arouse the researcher's vigilance, and some other abnormal factors should be excluded. If the amount of medicine dispensed is calculated based on the weight of the current visit, these potential problems cannot be found. Therefore, the method of the present application is used to calculate the amount of medicine dispensed to avoid the problem of abnormal dynamic dosage conditions caused by human operation or equipment failure, thereby dispensing the wrong medicine, thereby achieving the technical effect of saving the amount of medicine dispensed.
[0069] In order to better achieve the ultimate goal of saving the amount of medicine dispensed, the present application also specifically designs the dispensing rules. In one embodiment, the dynamic dosage conditions are analyzed, and according to the dispensing rules, the amount of medicine dispensed for the subject during the current visit is determined based on the amount of medicine dispensed during the subject's last visit, including:
[0070] Determine whether the dynamic dosage conditions of the subject at the current visit have changed relative to the dynamic dosage conditions of the subject at the previous visit;
[0071] If not, the medication amount of the subject at the last visit is output as the medication amount of the subject at the current visit;
[0072] If so, it is necessary to further determine whether the change meets the preset conditions;
[0073] If the preset conditions are not met, the amount of medicine dispensed at the subject's last visit will be output as the amount of medicine dispensed at the subject's current visit;
[0074] If the preset conditions are met, the medication amount of the subject at the previous visit is adjusted to determine a new medication dosage level, and the new medication dosage level is output as the medication amount of the subject at the current visit.
[0075] First of all, the preset conditions in the above logical judgments are constraints designed by researchers based on historical experience or optimal models to meet the clinical trial effect while achieving the minimum drug delivery amount; researchers can set different constraints according to different project requirements. For example, if the project effect is sensitive to dynamic dose conditions, and a slight change in the dynamic dose conditions requires a change in the drug delivery amount, then the constraints defined by the preset conditions are narrower; if the project effect is not sensitive to the dynamic dose conditions, then the constraints defined by the preset conditions are wider, allowing the dynamic dose conditions to change within a larger range without affecting the drug delivery amount. The advantage of this setting is that, on the one hand, it can save the drug delivery amount compared to the method of calculating the drug delivery amount based on a single factor of the dynamic dose condition. On the other hand, this method has strong applicability. Researchers can set preset conditions according to different project requirements to form a constraint relationship between the change of dynamic dose conditions and the drug delivery amount.
[0076] In one embodiment, the preset conditions include: a first preset condition and a second preset condition, wherein the first preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's previous visit is greater than or equal to the first preset threshold value A1 and less than or equal to the second preset threshold value A2, that is, A1≤|Q2-Q1|≤A2, wherein Q2, Q1, A1, and A2 are all greater than 0.
[0077] The second preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's previous visit is greater than a second preset threshold, |Q2-Q1|>A2.
[0078] Specifically, A1 and A2 can be equal, unequal, or zero, which can be set according to different clinical trial research purposes. When A1=A2=0, it means that once the dynamic dose conditions of the subject in the current visit are changed compared with the dynamic dose conditions of the previous visit, the drug dose level of the subject in the current visit must change accordingly; when A1≠A2, when 0≤|Q2-Q1|≤A1, it means that the clinical trial allows the dynamic dose conditions of the subject in the current visit to change slightly relative to the dynamic dose conditions of the previous visit, without adjusting the drug dose level of the current visit, that is, the drug dose level of the current visit is equal to the drug dose level of the previous visit.
[0079] According to an embodiment of the present invention, by setting two preset conditions in the preset conditions, the method can improve its project applicability and, by setting constraints on the size range, can achieve the minimum drug delivery amount while meeting project requirements, thereby saving the drug delivery amount of the project.
[0080] In another embodiment, the preset condition may include only the first preset condition or the second preset condition, or may include not only the first preset condition and the second preset condition, but may also include an Nth preset condition, where N is an integer greater than 2. The more preset conditions are set, the more constraints are set between the changes between the dynamic dosage conditions and the drug delivery amount, and the more it is possible to achieve the minimum drug delivery amount while meeting the project requirements, thereby saving the drug delivery amount of the project.
[0081] In one embodiment, adjusting the medication dose dispensed by the subject at the last visit to determine a new medication dosage level comprises:
[0082] When the change satisfies the first preset condition, the new drug dosage level is determined by increasing or decreasing the drug dosage level of the drug dispensing amount of the subject at the last visit within the dosage condition interval to which the dynamic dosage condition of the subject at the last visit belongs;
[0083] When the change meets the second preset condition, a new dosage condition interval is adjusted and determined based on the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and the drug dosage level is determined within the new dosage condition interval as the new drug dosage level according to the dynamic dosage condition of the subject's current visit.
[0084] Specifically, whether to increase or decrease the first dose level to determine the second dose level is determined based on the relationship between the dynamic dose condition and the amount of medication administered to the subject. If the two are positively correlated, when Q2>Q1, the first dose level needs to be increased to determine the second dose level; when Q2<Q1, the first dose level needs to be decreased to determine the second dose level; if the two are negatively correlated, when Q2>Q1, the first dose level needs to be decreased to determine the second dose level; when Q2<Q1, the first dose level needs to be increased to determine the second dose level; this can be specifically set according to different clinical trial research purposes.
[0085] By determining the amount of medication to be dispensed by adjusting the drug dosage level upward or downward, researchers can intuitively determine the changes in the subjects throughout the entire trial process, which facilitates later analysis of trial results and error checking during the trial process.
[0086] In one embodiment, the above method further includes: determining whether the subject's current visit is the subject's first visit; if so, recording the dynamic dosage conditions of the subject's first visit, and determining and recording the amount of medicine dispensed for the subject's first visit according to the medicine dispensing rules; if not, recording the dynamic dosage conditions of the subject's current visit, and obtaining the dynamic dosage conditions of the subject's last visit and the amount of medicine dispensed for the subject's last visit, and determining and recording the amount of medicine dispensed for the subject's current visit according to the medicine dispensing rules. This method automatically stores the historical data of each visit, which is convenient for the retrieval and use of data in the subsequent calculation of the amount of medicine dispensed, thereby improving the efficiency of the calculation.
[0087] In one embodiment, determining the medication amount for the first visit of a subject according to medication dispensing rules includes: according to a calculation rule, after confirming the dosage condition interval corresponding to the dynamic dosage condition of the subject's last visit, obtaining the drug dosage level corresponding to the dosage condition interval and defining it as a first dosage level, and the first dosage level is used as the medication amount for the subject's last visit; wherein the calculation rule includes dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels.
[0088] Specifically, according to the calculation rules, after confirming the dose condition interval corresponding to the dynamic dose condition of the subject's first visit, the drug dose level corresponding to the dose condition interval is obtained and defined as the first dose level, and the first dose level is used as the drug delivery amount of the subject's last visit. That is, according to the dose condition after the subject's first visit, a dose condition interval is determined, and the drug delivery amount determined for the first time in this dose condition interval is recorded as the first dose level, i.e., the basic dose level. The next drug delivery can be automatically adjusted (upward or downward) on the basic dose level to obtain the second dose level and the third dose level; if the subject's dose information changes the previous dose condition interval during the visit, the first dose level determined by the subject in the new dose condition interval is used as the basic dose level.
[0089] According to an embodiment of the present invention, the amount of medicine dispensed to the subject in the first way is taken as the first dosage level, that is, as the basic dosage, and then the new dosage is determined by adjusting upward or downward on this basis, and successively becomes the second dosage level and the third dosage level, etc., so that researchers can clearly manage the process of drug dispensing, and through the action of adjusting upward or downward, they can intuitively understand the changes of the subjects during the trial, thereby improving the user experience.
[0090] In one embodiment, the method further includes: after determining the amount of medication dispensed for the subject during the current visit, further determining whether the subject's current visit is the subject's last visit; if not, continuing to obtain the subject's dynamic dosage conditions; if yes, ending the subject's medication dispensing process.
[0091] The embodiment of the present invention uses the last visit of the subject as the time node for ending the medication dispensing process, thereby saving the allocation of labor costs in the project and enabling researchers to grasp the progress of the project more promptly.
[0092] Example 2
[0093] like Figure 2 The flowchart of an exemplary method for determining the amount of medicine to be dispensed in a clinical trial of the present application is shown as an example. The program operation flow of the method for calculating the amount of medicine to be dispensed in the system for clinical trials is specifically introduced as an example. The clinical project research of drug A is taken as an example. The amount of medicine to be dispensed each time is automatically adjusted according to the weight of the subject as dosage information. After the system starts running, the following steps are included:
[0094] 210: The program starts running.
[0095] 220: Get the drug dispensing rules.
[0096] In the clinical trial of Drug A, the clinical researcher set the dynamic dosage condition to the subject's weight based on the project objective of the clinical trial, and the drug dispensing rules included calculation rules and adjustment rules.
[0097] In one embodiment, the calculation rules include that the amount of medicine dispensed increases with the increase in body weight, and two dosage condition intervals are set, and three drug dosage levels are set in each dosage condition interval, that is, in the first dosage condition interval, the body weight of the subject is greater than k, and the drug dosage levels are o, p, and q, respectively, where p<o<q; in the second dosage condition interval, the body weight of the subject is ≤k, and the drug dosage levels are r, s, and t, respectively, where s<r<t.
[0098] The adjustment conditions are: when the subject's body weight is greater than k, the basic dose level is adjusted upward; when the subject's body weight is less than or equal to k, the basic dose level is adjusted downward.
[0099] After the researcher has completed the configuration of the medication dispensing rules in the system, he or she can then create a new database file for the subject in the system and start the subject's first visit.
[0100] 230: Obtain the dynamic dosage condition Q1 of the subject's first visit.
[0101] Specifically, it can be obtained by a researcher entering the information into the system, or by the system's image recognition, voice recognition, etc. This embodiment does not make any specific limitation here.
[0102] For example, the subject's weight at visit 1 is k+9.
[0103] 240: Calculate the medication amount of the subject's first visit according to the medication dispensing rules;
[0104] The subject's weight at the first visit is greater than k, which determines that the subject belongs to the first dosage condition interval, and the default amount of drug at the first dosage level of the dosage condition interval is dispensed, that is, the drug amount dispensed is o. At the same time, the system records the dynamic dosage conditions of the subject's first visit, that is, weight k+9 and drug amount dispensed o.
[0105] After obtaining the amount of medication dispensed by the subject in the first visit through the system, the clinical researcher dispenses the medication to the subject and waits until the second visit.
[0106] 250: Obtain the dynamic dosage condition Q2 of the subject's current visit, i.e., the second visit.
[0107] Similarly, it can be obtained by researchers entering data into the system, or by the system's image recognition, voice recognition, etc. This embodiment does not make any specific limitation here.
[0108] For example, the subject's weight at visit 2 is k+3.
[0109] 260: Determine whether the dynamic dosage conditions of the subject at the current visit have changed relative to the dynamic dosage conditions of the subject at the previous visit, that is, determine whether the dynamic dosage conditions of the subject at the second visit have changed relative to the dynamic dosage conditions of the subject at the first visit.
[0110] 261: If no, output the first dose level as the dose dispensed for the subject at that visit, i.e., the second visit.
[0111] 262: If yes, it is necessary to further determine whether the change meets the preset conditions.
[0112] 263: If the preset conditions are not met, the first dose level will be output as the medication amount for the subject's current visit, i.e., the second visit.
[0113] 264: If the preset condition is met, it is necessary to further determine whether the change meets the first preset condition or the second preset condition.
[0114] 265: If the first preset condition A1≤|Q2-Q1|≤A2 is met, the first dose level is increased or decreased within the dose condition interval to which the first dose level belongs to determine the second dose level, and the second dose level is the new drug dose level.
[0115] 266: If the second preset condition |Q2-Q1|>A2 is met, a new dosage condition interval is adjusted and determined based on the dosage condition interval to which the first dosage level belongs, and the drug dosage level determined within the new dosage condition interval corresponding to the dynamic dosage condition of the subject at the current visit is used as the new drug dosage level, and the new drug dosage level is used as the first dosage level within the new dosage condition interval.
[0116] Clinical researchers administer medication to subjects based on the system's output.
[0117] 270: Determine whether the current visit is the last visit.
[0118] If yes, the system calculation procedure ends;
[0119] If no, restart from step 250.
[0120] Specifically, at the second visit, the subject's weight is k+3. First, k+3 is greater than k, and it still belongs to the first dose condition interval; that is, it meets the first preset condition, where A1 and A2 are equal and equal to 0. Therefore, according to the researcher's setting k+3<k+9, the first drug level of the first visit needs to be lowered, and the drug dose needs to be determined to be p as the second dose level of the second visit, that is, the amount of medication.
[0121] If the second visit is not the last visit, the subject's weight at the third visit is k-2. At this time, the subject's weight is less than k, so the dosage condition interval is changed from the original first dosage condition interval to the second dosage condition interval, and the first dosage level in the second dosage condition interval is used as the drug dosage, that is, r drugs should be administered.
[0122] The system for clinical trials provided in this embodiment can be used to calculate the amount of medicine dispensed after a visit to a subject in the clinical trial, replacing the manual calculation in the prior art, thereby avoiding the problem of errors caused by manual calculation and reducing subjective errors.
[0123] Example 3
[0124] like Figure 3 The present application is shown as an exemplary system for determining the amount of medicine to be dispensed in a clinical trial, the system comprising: an acquisition module 310, for acquiring the dynamic dosage conditions of the subject and the medicine dispensing rules of the clinical trial; a determination module 320, for determining the amount of medicine to be dispensed for the subject in the current visit according to the medicine dispensing rules based on the dynamic dosage conditions.
[0125] In another embodiment, the system embeds medication dispensing rules and dynamic dosage conditions, and the amount of medication dispensed to the subject is dynamically adjusted as the dynamic dosage conditions change. The system automatically adjusts the amount of medication dispensed based on the dosage conditions of the subject at each visit. Automatic adjustment means that medication dispensing does not require manual selection and is automatically calculated to display the medication dosage level for the dosage condition interval to be dispensed.
[0126] In another embodiment, the specific steps of implementing the medication dispensing rule include:
[0127] Set up clinical projects to select dynamic dosage conditions for drug dispensing;
[0128] Set the adjustment method of the drug delivery amount to automatic adjustment based on the subject's dosage information;
[0129] Configure dose level intervals and dose condition intervals (dose information can be selected) in clinical projects; among them, the dose condition in the treatment plan is the "dose condition interval";
[0130] Set up drug dispensing rules: All subjects will select the first dose level drug by default when dispensing drugs for the first time; the system needs to record the dose level of each drug used by the subject in this visit as the basic dose, and the next dispensing can be automatically adjusted (upward or downward) based on the basic dose level; if the dose information of the subject changes the dose condition range during the visit, the first dose will be used as the basic dose level again;
[0131] The dosage information of the subject's visit is recorded, and the system automatically calculates the drug dosage level, i.e., the amount of medicine to be dispensed this time.
[0132] In another embodiment, the system is based on springboot MVC (model-view-controller) implementation technology, and is embedded in the program operation process according to certain drug dispensing rules. When the researcher dispenses the drug to the subject, the system automatically calculates the dose of the drug after inputting the subject's dosage information. Each dose of the drug is implemented according to the latest dosage conditions of the subject at that time.
[0133] According to an embodiment of the present invention, the medication dispensing rules include: calculation rules and adjustment rules, wherein the calculation rules include dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels; the adjustment rules include that as the dynamic dosage conditions of the subject's current visit change relative to the dynamic dosage conditions of the subject's last visit, the medication dispensing amount of the subject's current visit will change or remain unchanged based on the medication dosage level of the subject's last visit.
[0134] According to an embodiment of the present invention, the determination module 320 is specifically used to obtain the dynamic dosage conditions of the subject's last visit and the amount of medicine dispensed during the subject's last visit; analyze the dynamic dosage conditions, and determine the amount of medicine dispensed for the subject during the current visit based on the amount of medicine dispensed during the subject's last visit according to the medicine dispensing rules.
[0135] According to an embodiment of the present invention, the determination module 320 is specifically used to determine whether the dynamic dosage conditions of the subject's current visit have changed relative to the dynamic dosage conditions of the subject's last visit; if not, the amount of medicine dispensed at the subject's last visit is output as the amount of medicine dispensed at the subject's current visit; if so, it is necessary to further determine whether the change meets the preset conditions; if the preset conditions are not met, the amount of medicine dispensed at the subject's last visit is output as the amount of medicine dispensed at the subject's current visit; if the preset conditions are met, the amount of medicine dispensed at the subject's last visit is adjusted to determine a new drug dosage level, and the new drug dosage level is output as the amount of medicine dispensed at the subject's current visit.
[0136] According to an embodiment of the present invention, the preset conditions include: a first preset condition and a second preset condition, wherein the first preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's last visit is greater than or equal to the first preset threshold value A1 and less than or equal to the second preset threshold value A2, that is, A1≤|Q2-Q1|≤A2, wherein Q2, Q1, A1, and A2 are all greater than 0.
[0137] According to an embodiment of the present invention, the second preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's previous visit is greater than a second preset threshold, |Q2-Q1|>A2.
[0138] According to an embodiment of the present invention, adjusting the amount of medicine dispensed at the subject's last visit to determine a new drug dosage level includes: when the change meets the first preset condition, increasing or decreasing the drug dosage level of the amount of medicine dispensed at the subject's last visit within the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs to determine the new drug dosage level; when the change meets the second preset condition, adjusting and determining the new dosage condition interval based on the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and determining the drug dosage level within the new dosage condition interval according to the dynamic dosage condition of the subject's current visit as the new drug dosage level.
[0139] Optionally, as another embodiment, the determination module 320 is also used to determine whether the current visit of the subject is the subject's first visit. If so, the dynamic dosage conditions of the subject's first visit are recorded, and the amount of medicine dispensed for the subject's first visit is determined and recorded according to the medicine dispensing rules; if not, the dynamic dosage conditions of the subject's current visit are recorded, and the dynamic dosage conditions of the subject's last visit and the amount of medicine dispensed for the subject's last visit are obtained, and the amount of medicine dispensed for the subject's current visit is determined and recorded according to the medicine dispensing rules.
[0140] According to an embodiment of the present invention, the determination module 320 is further used to obtain the drug dosage level corresponding to the dosage condition interval and define it as the first dosage level after confirming the dosage condition interval corresponding to the dynamic dosage condition of the subject's first visit according to the calculation rules, and the first dosage level is used as the drug dispensing amount for the subject's first visit; wherein the calculation rules include dividing different dynamic dosage conditions into different dosage condition intervals, and different dosage condition intervals are respectively provided with different drug dosage levels.
[0141] Optionally, as another embodiment, the determination module 320 is also used to further determine whether the current visit of the subject is the subject's last visit after determining the amount of medication dispensed during the current visit; if not, continue to obtain the subject's dynamic dosage conditions; if yes, end the subject's medication dispensing process.
[0142] The present application also provides an exemplary computer-readable storage medium, which stores a computer program for executing any of the above methods for determining the amount of medicine to be dispensed in a clinical trial.
[0143] Example 4
[0144] This embodiment provides an electronic device, referring to Figure 4 The electronic device 400 includes a processing component 410, which further includes one or more processors, and a memory resource represented by a memory 420 for storing instructions executable by the processing component 410, such as an application. The application stored in the memory 420 may include one or more modules, each corresponding to a set of instructions. In addition, the processing component 410 is configured to execute instructions to perform the above-mentioned method for determining the amount of medicine to be dispensed in a clinical trial.
[0145] The electronic device 400 may also include a power supply component configured to perform power management of the electronic device 400, a wired or wireless network interface configured to connect the electronic device 400 to a network, and an input / output (I / O) interface. The electronic device 400 may be operated based on an operating system stored in the memory 420, such as Windows Server 2008. TM , Mac OSX TM , Unix TM , Linux TM , FreeBSD TM or similar.
[0146] A non-temporary computer-readable storage medium, when the instructions in the storage medium are executed by the processor of the above-mentioned electronic device 400, enables the above-mentioned electronic device 400 to execute a method for determining the amount of medicine to be dispensed in a clinical trial, including: obtaining the dynamic dosage conditions of the subject, the dynamic dosage conditions including the dynamic dosage conditions of the subject's current visit and the dynamic dosage conditions of the subject's previous visit; based on the dynamic dosage conditions, determining the amount of medicine to be dispensed for the subject in the current visit according to the medicine dispensing rules.
[0147] In summary, the present application provides a method and system for determining the amount of medicine to be dispensed in a clinical trial, the method comprising obtaining the dynamic dosage conditions of the subject, the dynamic dosage conditions comprising the dynamic dosage conditions of the subject's current visit and the dynamic dosage conditions of the subject's last visit; based on the dynamic dosage conditions, determining the amount of medicine to be dispensed for the subject's current visit according to the medicine dispensing rules. This method can reduce errors in human calculations during the drug dispensing process in clinical trials, save the amount of medicine to be dispensed, and avoid unnecessary waste of medicines.
[0148] All the above optional technical solutions can be arbitrarily combined to form optional embodiments of the present application, and will not be described in detail here.
[0149] Those of ordinary skill in the art will appreciate that the units and algorithm steps of each example described in conjunction with the embodiments disclosed herein can be implemented in electronic hardware, or a combination of computer software and electronic hardware. Whether these functions are performed in hardware or software depends on the specific application and design constraints of the technical solution. Professional and technical personnel can use different methods to implement the described functions for each specific application, but such implementation should not be considered to be beyond the scope of this application.
[0150] Those skilled in the art can clearly understand that, for the convenience and brevity of description, the specific working processes of the systems, devices and units described above can refer to the corresponding processes in the aforementioned method embodiments and will not be repeated here.
[0151] In the several embodiments provided in the present application, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic. For example, the division of the units is only a logical function division. There may be other division methods in actual implementation, such as multiple units or components can be combined or integrated into another system, or some features can be ignored or not executed. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be through some interfaces, indirect coupling or communication connection of devices or units, which can be electrical, mechanical or other forms.
[0152] The units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, that is, they may be located in one place or distributed on multiple network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of this embodiment.
[0153] In addition, each functional unit in each embodiment of the present application may be integrated into one processing unit, or each unit may exist physically separately, or two or more units may be integrated into one unit.
[0154] If the functions are implemented in the form of software functional units and sold or used as independent products, they can be stored in a computer-readable storage medium. Based on this understanding, the technical solution of the present application can be essentially or partly embodied in the form of a software product that contributes to the prior art. The computer software product is stored in a storage medium, including several instructions to enable a computer device (which can be a personal computer, a server, or a network device, etc.) to perform all or part of the steps of the methods described in each embodiment of the present application. The aforementioned storage medium includes: various media that can store program check codes, such as a USB flash drive, a mobile hard disk, a read-only memory (ROM), a random access memory (RAM), a magnetic disk or an optical disk.
[0155] It should be noted that, in the description of this application, the terms "first", "second", "third", etc. are used for descriptive purposes only and cannot be understood as indicating or implying relative importance. In addition, in the description of this application, unless otherwise specified, the meaning of "plurality" is two or more.
[0156] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions, etc. made within the spirit and principles of the present application shall be included in the protection scope of the present application.
Claims
1. A method for determining the amount of medicine to be dispensed in a clinical trial, characterized in that: include: Acquiring the dynamic dosage conditions of the subject, wherein the dynamic dosage conditions include the dynamic dosage conditions of the subject at the current visit and the dynamic dosage conditions of the subject at the previous visit; Obtaining the dynamic dosage conditions of the subject at the last visit and the amount of medicine dispensed at the subject at the last visit; Analyze the dynamic dosage conditions, and determine the dosage of the subject for the current visit based on the dosage of the subject for the last visit according to the drug dispensing rules, wherein the drug dispensing rules include calculation rules and adjustment rules, wherein the calculation rules include dividing different dynamic dosage conditions into different dosage condition intervals, and the different dosage condition intervals are respectively provided with different drug dosage levels, and the adjustment rules include that as the dynamic dosage conditions of the subject for the current visit change relative to the dynamic dosage conditions of the subject for the last visit, the dosage of the subject for the current visit will change or remain unchanged based on the dosage level of the dosage of the subject for the last visit; The analyzing the dynamic dosage conditions and determining the medication amount for the subject in the current visit based on the medication amount for the subject in the previous visit according to the medication dispensing rules include: Determining whether the dynamic dosage conditions of the subject at the current visit have changed relative to the dynamic dosage conditions of the subject at the previous visit; If not, output the medication amount of the subject in the previous visit as the medication amount of the subject in the current visit; If so, it is necessary to further determine whether the change satisfies a preset condition. If the preset condition is not satisfied, the medication amount of the subject at the last visit is output as the medication amount of the subject at the current visit. If the preset condition is satisfied, the medication amount of the subject at the last visit is adjusted to determine a new medication dosage level, and the new medication dosage level is output as the medication amount of the subject at the current visit. The preset condition includes a first preset condition and a second preset condition. The first preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject at the current visit and the dynamic dosage condition Q1 of the subject at the previous visit is greater than or equal to a first preset threshold value A1 and less than or equal to a second preset threshold value A2, that is, A1≤|Q2 - Q1|≤A2. The second preset condition is that the absolute value of the difference between the dynamic dosage condition Q2 of the subject at the current visit and the dynamic dosage condition Q1 of the subject at the previous visit is greater than the second preset threshold value, |Q2 - Q1|>A2, the adjusting of the medication amount dispensed at the last visit of the subject to determine a new medication dosage level, includes, when the change satisfies the first preset condition, increasing or decreasing the medication dosage level of the medication amount dispensed at the last visit within the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs to determine the new medication dosage level, and when the change satisfies the second preset condition, adjusting and determining a new dosage condition interval based on the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and determining the medication dosage level within the new dosage condition interval corresponding to the dynamic dosage condition of the subject's current visit as the new medication dosage level.
2. The method according to claim 1, characterized in that Also includes: Determining whether the current visit of the subject is the first visit of the subject; If yes, record the dynamic dosage conditions of the subject's first visit, and determine and record the medication amount of the subject's first visit according to the medication dispensing rules; If not, record the dynamic dosage conditions of the subject in the current visit, obtain the dynamic dosage conditions of the subject in the last visit and the amount of medicine dispensed in the subject in the last visit, and determine and record the amount of medicine dispensed in the current visit of the subject according to the medicine dispensing rules.
3. The method according to claim 2, characterized in that Determining the medication amount for the first visit of the subject according to the medication dispensing rule includes: According to the calculation rules, after confirming the dosage condition interval corresponding to the dynamic dosage condition of the subject's first visit, the drug dosage level corresponding to the dosage condition interval is obtained and defined as the first dosage level, and the first dosage level is used as the drug dispensing amount of the subject's first visit; wherein, The calculation rule includes dividing different dynamic dosage conditions into different dosage condition intervals, and the different dosage condition intervals are respectively provided with different drug dosage levels.
4. The method according to any one of claims 1 to 3, characterized in that Also includes: After determining the amount of medicine dispensed by the subject during the current visit, further determining whether the current visit of the subject is the last visit of the subject; If no, proceed to obtain dynamic dosing conditions for the subject; If yes, end the medication dispensing process for the subject.
5. A system for clinical trials, characterized in that: The system comprises a determination module and an acquisition module for acquiring the dynamic dosage conditions of the subject and the drug dispensing rules of the clinical trial; Wherein, the determination module is used to obtain the dynamic dosage conditions of the subject's last visit and the amount of medicine dispensed at the subject's last visit, and analyze the dynamic dosage conditions, and determine the amount of medicine dispensed at the subject's current visit based on the amount of medicine dispensed at the subject's last visit according to the medicine dispensing rules, wherein the medicine dispensing rules include calculation rules and adjustment rules, the calculation rules include dividing different dynamic dosage conditions into different dosage condition intervals, and the different dosage condition intervals are respectively provided with different drug dosage levels, and the adjustment rules include that as the dynamic dosage conditions of the subject's current visit change relative to the dynamic dosage conditions of the subject's last visit, the amount of medicine dispensed at the subject's current visit will change or not change the drug dosage level based on the drug dosage level at which the amount of medicine dispensed at the subject's last visit is located; The determination module is used to determine whether the dynamic dosage condition of the subject at the current visit has changed relative to the dynamic dosage condition of the subject at the previous visit. If not, the drug dispensing amount of the subject at the previous visit is output as the drug dispensing amount of the subject at the current visit. If so, it is necessary to further determine whether the change meets a preset condition. If the preset condition is not met, the drug dispensing amount of the subject at the previous visit is output as the drug dispensing amount of the subject at the current visit. If the preset condition is met, the drug dispensing amount of the subject at the previous visit is adjusted to determine a new drug dosage level, and the new drug dosage level is output as the drug dispensing amount of the subject at the current visit. Wherein, the step of adjusting the drug dispensing amount of the subject at the previous visit to determine a new drug dosage level includes when the change meets a first preset condition, The new drug dosage level is determined by increasing or decreasing the drug dosage level of the drug dosage amount of the subject's last visit within the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and when the change satisfies a second preset condition, a new dosage condition interval is adjusted and determined based on the dosage condition interval to which the dynamic dosage condition of the subject's last visit belongs, and the drug dosage level is correspondingly determined within the new dosage condition interval according to the dynamic dosage condition of the subject's current visit as the new drug dosage level, the first preset condition being that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's last visit is greater than or equal to a first preset threshold value A1 and less than or equal to a second preset threshold value A2, that is, A1≤|Q2 - Q1|≤A2, wherein Q2, Q1, A1, and A2 are all greater than 0, and the second preset condition being that the absolute value of the difference between the dynamic dosage condition Q2 of the subject's current visit and the dynamic dosage condition Q1 of the subject's last visit is greater than the second preset threshold value, |Q2 - Q1|>A2; The determination module is used to determine whether the current visit of the subject is the first visit of the subject, if yes, record the dynamic dosage conditions of the first visit of the subject, and determine and record the medication amount of the first visit of the subject according to the medication dispensing rule; if no, record the dynamic dosage conditions of the current visit of the subject, and obtain the dynamic dosage conditions of the last visit of the subject and the medication amount of the last visit of the subject, and determine and record the medication amount of the current visit of the subject according to the medication dispensing rule; The determination module is used to confirm the dosage condition interval corresponding to the dynamic dosage condition of the subject's first visit according to the calculation rule, obtain the drug dosage level corresponding to the dosage condition interval and define it as a first dosage level, and the first dosage level is used as the drug dispensing amount of the subject's first visit, wherein the calculation rule includes dividing different dynamic dosage conditions into different dosage condition intervals, and the different dosage condition intervals are respectively provided with different drug dosage levels; The determination module is also used to further determine whether the current visit of the subject is the last visit of the subject after determining the amount of medicine dispensed for the subject in the current visit. If not, continue to obtain the dynamic dosage conditions of the subject. If yes, end the medicine dispensing process for the subject.
6. A computer-readable storage medium storing a computer program for executing the method for determining the amount of medication to be dispensed in a clinical trial as described in any one of claims 1 to 4.
7. An electronic device, comprising: processor; a memory for storing instructions executable by the processor; Wherein, the processor is used to execute the method for determining the amount of medicine to be dispensed in clinical trials as described in any one of claims 1 to 4 above.
